We are live on ! Find out more
HA

HC Advisors Portfolio holdings

AUM $165M
1-Year Est. Return 20.85%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+20.85%
3 Year Est. Return
+63.52%
5 Year Est. Return
+65.27%
10 Year Est. Return
AUM
$155M
AUM Growth
+$8.44M
Cap. Flow
+$3.22M
Cap. Flow %
2.08%
Top 10 Hldgs %
63.18%
Holding
102
New
15
Increased
35
Reduced
19
Closed
13

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.97%
2 Financials 2.81%
3 Technology 2.61%
4 Healthcare 2.33%
5 Consumer Discretionary 1.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTK icon
76
Cytokinetics
CYTK
$9.64B
$210K 0.14%
9,009
-20,683
-70% -$442K
CVX icon
77
Chevron
CVX
$427B
$206K 0.13%
+1,962
New +$192K
BDTX icon
78
Black Diamond Therapeutics
BDTX
$113M
$202K 0.13%
8,330
-137
-2% -$3.69K
GPC icon
79
Genuine Parts
GPC
$18.1B
$201K 0.13%
+1,738
New +$185K
PM icon
80
Philip Morris
PM
$303B
$199K 0.13%
+2,241
New +$190K
BX icon
81
Blackstone
BX
$95.1B
$197K 0.13%
+2,641
New +$182K
T icon
82
AT&T
T
$183B
$195K 0.13%
+8,546
New +$189K
AWP
83
abrdn Global Premier Properties Fund
AWP
$337M
$190K 0.12%
10,624
-286
-3% -$4.73K
PASG icon
84
Passage Bio
PASG
$15.3M
$179K 0.12%
+512
New +$219K
GE icon
85
GE Aerospace
GE
$319B
$139K 0.09%
+2,125
New +$129K
EQX icon
86
Equinox Gold
EQX
$13.8B
$136K 0.09%
17,011
-1,853
-10% -$17.1K
NGD
87
DELISTED
New Gold Inc
NGD
$132K 0.09%
85,700
+47,800
+126% +$86.4K
TINV.WS
88
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$51K 0.03%
+39,380
New +$72.8K
KSMTW
89
DELISTED
Kismet Acquisition One Corp Warrant
KSMTW
$13K 0.01%
+16,200
New +$19K
AKBA icon
90
Akebia Therapeutics
AKBA
$250M
-14,000
Closed -$39K
BNTX icon
91
BioNTech
BNTX
$24.3B
-4,072
Closed -$332K
CLDX icon
92
Celldex Therapeutics
CLDX
$3.02B
-14,791
Closed -$259K
COGT icon
93
Cogent Biosciences
COGT
$5.68B
-31,395
Closed -$353K
ETNB
94
DELISTED
89bio
ETNB
-10,826
Closed -$264K
FIS icon
95
Fidelity National Information Services
FIS
$19.3B
-2,000
Closed -$283K
HDGE icon
96
AdvisorShares Ranger Equity Bear ETF
HDGE
$57.8M
-2,500
Closed -$76K
MTCH icon
97
Match Group
MTCH
$10.2B
-2,158
Closed -$326K
SRPT icon
98
Sarepta Therapeutics
SRPT
$2.19B
-4,282
Closed -$730K
TGTX icon
99
TG Therapeutics
TGTX
$8.12B
-12,834
Closed -$668K
SILV
100
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
-11,695
Closed -$131K

Similar funds

HC Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, HC Advisors held 102 positions worth $155M, up 5.8% from $146M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

HC Advisors's Q1 2021 filing shows 15 new, 35 increased, 19 reduced and 13 closed positions. Its largest new stake was Verizon: 11,714 shares worth $681K. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $921K.

By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, up from 87% a quarter earlier, followed by Financials and Technology.

  • HC Advisors's largest Q1 2021 buy was Verizon: 11,714 shares worth $681K.
  • HC Advisors added most to Bank of America in Q1 2021, an estimated $1.22M increase.
  • HC Advisors's biggest Q1 2021 reduction was Cytokinetics, cutting an estimated $442K.
  • HC Advisors fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2021, selling an estimated $921K.
  • HC Advisors's ten largest holdings make up 63% of its $155M portfolio in Q1 2021.
  • HC Advisors opened 15 new positions and closed 13 in Q1 2021.
  • HC Advisors's portfolio value rose 5.8% quarter-over-quarter to $155M.

Based on HC Advisors's 13F filing for Q1 2021, filed 7 May 2021.